Prognostic Value of Neoadjuvant Chemotherapy in Patients with Borderline Resectable Pancreatic Carcinoma Followed by Pancreatectomy with Portal Vein Resection and Reconstruction with Venous Allograft

Background: Neo-adjuvant chemotherapy (NAC) represents one of the current research hotspots in the field of pancreatic ductal adenocarcinoma (PDAC). The aim of this study is to evaluate the prognostic value of NAC in patients with borderline resectable pancreatic cancer (BRPC) followed by pancreatec...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jin-Can, Pan, Bing, Wang, Han-Xuan, Chen, Qing, He, Qiang, Lyu, Shao-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787949/
https://www.ncbi.nlm.nih.gov/pubmed/36555996
http://dx.doi.org/10.3390/jcm11247380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787949/
https://www.ncbi.nlm.nih.gov/pubmed/36555996
http://dx.doi.org/10.3390/jcm11247380

Ejemplares similares